2022
Electronic Nicotine Delivery Systems: An Updated Policy Statement From the American Association for Cancer Research and the American Society of Clinical Oncology
Herbst RS, Hatsukami D, Acton D, Giuliani M, Moushey A, Phillips J, Sherwood S, Toll BA, Viswanath K, Warren NJH, Warren GW, Alberg AJ. Electronic Nicotine Delivery Systems: An Updated Policy Statement From the American Association for Cancer Research and the American Society of Clinical Oncology. Journal Of Clinical Oncology 2022, 40: 4144-4155. PMID: 36287017, DOI: 10.1200/jco.22.01749.Peer-Reviewed Original ResearchConceptsElectronic nicotine delivery systemsTobacco useENDS useCombustible tobaccoLong-term health risksEvidence-based treatmentsSurgeon General's ReportPublic healthNicotine delivery systemsTobacco-related disparitiesCombustible tobacco useBlood pressureSmoking cessationTobacco cessationCancer incidenceSmoking relapseClinical OncologyEpidemiological studiesImmune systemPotential efficacyE-cigarettesBrain developmentCancer developmentTobacco productsLongitudinal studyElectronic Nicotine Delivery Systems: An Updated Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology
Herbst RS, Hatsukami D, Acton D, Giuliani M, Moushey A, Phillips J, Sherwood S, Toll BA, Viswanath K, Warren NJH, Warren GW, Alberg AJ. Electronic Nicotine Delivery Systems: An Updated Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology. Clinical Cancer Research 2022, 28: of1-of10. PMID: 36287033, DOI: 10.1158/1078-0432.ccr-22-2429.Peer-Reviewed Original ResearchConceptsElectronic nicotine delivery systemsTobacco useENDS useCombustible tobaccoLong-term health risksEvidence-based treatmentsSurgeon General's ReportPublic healthNicotine delivery systemsTobacco-related disparitiesCombustible tobacco useBlood pressureSmoking cessationTobacco cessationCancer incidenceSmoking relapseClinical OncologyEpidemiological studiesImmune systemPotential efficacyE-cigarettesBrain developmentCancer developmentTobacco productsLongitudinal study
2016
Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research
Land SR, Toll BA, Moinpour CM, Mitchell SA, Ostroff JS, Hatsukami DK, Duffy SA, Gritz ER, Rigotti NA, Brandon TH, Prindiville SA, Sarna LP, Schnoll RA, Herbst RS, Cinciripini PM, Leischow SJ, Dresler CM, Fiore MC, Warren GW. Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research. Clinical Cancer Research 2016, 22: 1907-1913. PMID: 26888828, PMCID: PMC4861174, DOI: 10.1158/1078-0432.ccr-16-0104.Peer-Reviewed Original ResearchConceptsTobacco use assessmentCancer patientsTobacco useClinical trialsTobacco dependence treatmentSecondhand smoke exposureNIH Clinical CenterClinical treatment trialsAlternative tobacco productsTobacco Use QuestionnaireTobacco use statusEffect of cessationClinical cancer researchTiming of assessmentCancer researchCessation approachesProtocol therapyStudy entrySmoke exposureTask ForceCigarette smokingAdverse outcomesTreatment trialsClinical centersDependence treatment
2015
Electronic Nicotine Delivery Systems: A Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology
Brandon TH, Goniewicz ML, Hanna NH, Hatsukami DK, Herbst RS, Hobin JA, Ostroff JS, Shields PG, Toll BA, Tyne CA, Viswanath K, Warren GW. Electronic Nicotine Delivery Systems: A Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology. Clinical Cancer Research 2015, 21: 514-525. PMID: 25573384, DOI: 10.1158/1078-0432.ccr-14-2544.Peer-Reviewed Original ResearchConceptsElectronic nicotine delivery systemsTobacco useClinical OncologyHarm-reduction devicesNumber one preventable causeAmerican SocietyCombustible tobacco productsNicotine delivery systemsCancer researchCombustible tobacco useAdverse health effectsAmerican AssociationChildproof capsFormer smokersCigarette smokingPreventable causeSmoking ratesENDS useDefinitive dataE-cigarettesTobacco productsHealth effectsSmokersSmokingHealth impactsElectronic Nicotine Delivery Systems: A Policy Statement From the American Association for Cancer Research and the American Society of Clinical Oncology
Brandon TH, Goniewicz ML, Hanna NH, Hatsukami DK, Herbst RS, Hobin JA, Ostroff JS, Shields PG, Toll BA, Tyne CA, Viswanath K, Warren GW. Electronic Nicotine Delivery Systems: A Policy Statement From the American Association for Cancer Research and the American Society of Clinical Oncology. Journal Of Clinical Oncology 2015, 33: 952-963. PMID: 25572671, DOI: 10.1200/jco.2014.59.4465.Peer-Reviewed Original ResearchConceptsElectronic nicotine delivery systemsClinical OncologyTobacco useAmerican SocietyCancer researchHarm-reduction devicesNumber one preventable causeAmerican AssociationJoint writing groupCombustible tobacco productsClinical cancer researchNicotine delivery systemsCombustible tobacco useAdverse health effectsChildproof capsFormer smokersCigarette smokingPreventable causeTobacco cessationSmoking ratesUS FoodDrug AdministrationENDS useDefinitive dataElectronic cigarettes
2014
“Quitting Smoking Will Benefit Your Health”: The Evolution of Clinician Messaging to Encourage Tobacco Cessation
Toll BA, Rojewski AM, Duncan LR, Latimer-Cheung AE, Fucito LM, Boyer JL, O'Malley SS, Salovey P, Herbst RS. “Quitting Smoking Will Benefit Your Health”: The Evolution of Clinician Messaging to Encourage Tobacco Cessation. Clinical Cancer Research 2014, 20: 301-309. PMID: 24436474, PMCID: PMC3927319, DOI: 10.1158/1078-0432.ccr-13-2261.Peer-Reviewed Original ResearchConceptsCancer-related deathHeart diseaseTobacco useLung cancer-related deathsSubgroups of smokersBurden of cancerModerators of treatmentAdult patientsCessation interventionsSmoking cessationTobacco cessationQuitting smokingPreventable deathsGain-framed messagesSmokingTobacco productsCancerDiseaseDeathPatientsLungStrokeCessationHealthFuture studies
2013
Reducing Tobacco‐Related Cancer Incidence and Mortality: Summary of an Institute of Medicine Workshop
Balogh EP, Dresler C, Fleury ME, Gritz ER, Kean TJ, Myers ML, Nass SJ, Nevidjon B, Toll BA, Warren GW, Herbst RS. Reducing Tobacco‐Related Cancer Incidence and Mortality: Summary of an Institute of Medicine Workshop. The Oncologist 2013, 19: 21-31. PMID: 24304712, PMCID: PMC3903060, DOI: 10.1634/theoncologist.2013-0230.Peer-Reviewed Original ResearchAddressing Tobacco Use in Patients With Cancer: A Survey of American Society of Clinical Oncology Members
Warren GW, Marshall JR, Cummings KM, Toll BA, Gritz ER, Hutson A, Dibaj S, Herbst R, Mulshine JL, Hanna N, Dresler CA. Addressing Tobacco Use in Patients With Cancer: A Survey of American Society of Clinical Oncology Members. JCO Oncology Practice 2013, 9: 258-262. PMID: 23943904, PMCID: PMC3770508, DOI: 10.1200/jop.2013.001025.Peer-Reviewed Original ResearchConceptsCessation supportTobacco usePractice patternsASCO membersInitial visitCessation interventionsTobacco assessmentTobacco cessation supportTobacco cessation interventionsAmerican SocietyClinical Oncology membersClinical cancer careMost respondentsMedication optionsTobacco cessationCancer outcomesCancer careClinical OncologyPatientsPatient resistanceCancerOnline surveyCessationInterventionAdequate trainingAddressing tobacco use and cessation in cancer patients: Practices, perceptions, and barriers reported by oncology providers.
Warren G, Marshall J, Cummings K, Toll B, Gritz E, Hutson A, Dibaj S, Herbst R, Mulshine J, Hanna N, Dresler C. Addressing tobacco use and cessation in cancer patients: Practices, perceptions, and barriers reported by oncology providers. Journal Of Clinical Oncology 2013, 31: 1561-1561. DOI: 10.1200/jco.2013.31.15_suppl.1561.Peer-Reviewed Original ResearchTobacco cessation supportCancer patientsTobacco useOncology providersCessation supportTobacco cessationMedication optionsCancer outcomesClinical careTobacco cessation trainingMost respondentsCessation assistanceCessation trainingCessation treatmentCessation interventionsCessation practicesAdverse outcomesLung cancerCessation methodsTobacco assessmentInitial consultClinical OncologyPatientsPatient resistanceLack of timePractice Patterns and Perceptions of Thoracic Oncology Providers on Tobacco Use and Cessation in Cancer Patients
Warren GW, Marshall JR, Cummings KM, Toll B, Gritz ER, Hutson A, Dibaj S, Herbst R, Dresler C, Committee I. Practice Patterns and Perceptions of Thoracic Oncology Providers on Tobacco Use and Cessation in Cancer Patients. Journal Of Thoracic Oncology 2013, 8: 543-548. PMID: 23529191, PMCID: PMC3628367, DOI: 10.1097/jto.0b013e318288dc96.Peer-Reviewed Original ResearchConceptsCancer patientsTobacco useOncology providersPractice patternsClinical careInitial patient visitTobacco cessation activitiesLung cancer patientsTobacco cessation methodsCessation activitiesMedication optionsCessation assistanceCessation interventionsPoor outcomeSmoking cessationTobacco cessationCessation effortsCancer careLung cancerCessation methodsAffect OutcomesPatient visitsPhysician respondentsTobacco assessmentClinician educationAssessing Tobacco Use by Cancer Patients and Facilitating Cessation: An American Association for Cancer Research Policy Statement
Toll BA, Brandon TH, Gritz ER, Warren GW, Herbst RS, Tobacco and Cancer W. Assessing Tobacco Use by Cancer Patients and Facilitating Cessation: An American Association for Cancer Research Policy Statement. Clinical Cancer Research 2013, 19: 1941-1948. PMID: 23570694, PMCID: PMC5992896, DOI: 10.1158/1078-0432.ccr-13-0666.Peer-Reviewed Original ResearchConceptsTobacco useTobacco cessationCessation interventionsEvidence-based cessation interventionsTreatment-related toxicitySecond primary tumorsTobacco cessation interventionsQuality cancer careQuality of lifeAmerican AssociationCessation assistancePoor outcomeCancer careCancer patientsPrimary tumorOncology settingCancer recurrencePatientsTreatment efficacyTreatment settingsEvidence-based proceduresCancer leadCancerCancer progressionClinical infrastructure
2012
Tobacco Assessment in Actively Accruing National Cancer Institute Cooperative Group Program Clinical Trials
Peters EN, Torres E, Toll BA, Cummings KM, Gritz ER, Hyland A, Herbst RS, Marshall JR, Warren GW. Tobacco Assessment in Actively Accruing National Cancer Institute Cooperative Group Program Clinical Trials. Journal Of Clinical Oncology 2012, 30: 2869-2875. PMID: 22689794, PMCID: PMC3410402, DOI: 10.1200/jco.2011.40.8815.Peer-Reviewed Original ResearchConceptsCooperative group clinical trialsGroup clinical trialTobacco use assessmentClinical trialsTobacco useCancer treatment outcomesTreatment outcomesTobacco assessmentEvidence-based cessation supportPhase III trialsSecondhand smoke exposureClinical oncology practiceCooperative Group ProgramCancer clinical trialsCurrent cigarette useIII trialsSmoke exposureCessation supportNeck trialsOncology practiceNicotine dependenceRoutine assessmentCigarette useTrialsGroup program
2010
Tobacco and Cancer: An American Association for Cancer Research Policy Statement
Viswanath K, Herbst RS, Land SR, Leischow SJ, Shields PG, Tobacco and Cancer W. Tobacco and Cancer: An American Association for Cancer Research Policy Statement. Cancer Research 2010, 70: 3419-3430. PMID: 20388799, DOI: 10.1158/0008-5472.can-10-1087.Peer-Reviewed Original ResearchConceptsTobacco-related cancersTobacco useEvidence-based strategiesTobacco productsTobacco controlNew evidence-based strategiesEffective tobacco control strategiesTobacco-related deathsOncology clinical trialsEvidence-based behavioralFormer tobacco usersTobacco-related diseasesTobacco control programsEvidence-based treatmentsWorld Health Organization Framework ConventionTobacco control strategiesNew tobacco productsPublic healthAmerican AssociationAddictive componentTobacco cessationPharmacological treatmentClinical trialsTobacco usersEffective treatment
2003
Head and neck cancer
Kies M, Herbst R. Head and neck cancer. 2003, 207-216. DOI: 10.1017/cbo9780511527081.025.Peer-Reviewed Original ResearchSquamous cell cancerNeck malignanciesCell cancerNeck cancerTobacco useNeck squamous cell cancerIndependent risk factorEpstein-Barr virusFloor of mouthConsumption of fruitsDose-response relationshipSynergistic carcinogenic effectUncommon headAdvanced diseaseMost patientsMedian ageAnnual incidenceViral exposureCommon cancerRisk factorsTreatment outcomesIntroduction HeadBuccal mucosaNasopharyngeal carcinomaOral cavity